Privia Health Group Inc(PRVA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 94.52 | EPS (ttm) | 0.22 | Insider Own | 6.71% | Shs Outstand | 126.3M | Perf Week | -1.69% |
| Market Cap | 2.60B | Forward P/E | 48.83 | EPS next Y | 61.99% | Insider Trans | -8.78% | Shs Float | 119.2M | Perf Month | -7.32% |
| Enterprise Value | 2.25B | PEG | 1.04 | EPS next Q | 0.09 | Inst Own | 92.98% | Short Float | 4.44% | Perf Quarter | -11.05% |
| Income | 0.03B | P/S | 1.1 | EPS this Y | 43.08% | Inst Trans | 2.48% | Short Ratio | 4.35 | Perf Half Y | -7.7% |
| Sales | 2.36B | P/B | 3.29 | EPS next 5Y | 46.98% | ROA | 2.04% | Short Interest | 5.29M | Perf YTD | -14.09% |
| Book/sh | 6.19 | P/C | 6.31 | EPS past 3/5Y | - -9.67% | ROE | 3.84% | 52W High | -29.32% ($28.82) | Perf Year | -10.19% |
| Cash/sh | 3.23 | P/FCF | 20.03 | Sales past 3/5Y | 16.1% 21.04% | ROIC | 3.56% | 52W Low | 4.3% ($19.53) | Perf 3Y | -19.8% |
| Dividend Est. | - | EV/EBITDA | 39.59 | EPS Y/Y TTM | 84.08% | Gross Margin | 9.52% | Volatility(W/M) | 2.82% 2.62% | Perf 5Y | -30.88% |
| Dividend TTM | - | EV/Sales | 0.96 | Sales Y/Y TTM | 24.1% | Oper. Margin | 1.9% | ATR (14) | 0.67 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.62 | EPS Q/Q | 228.23% | Profit Margin | 1.19% | RSI (14) | 28 | Recom | 1.16 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.62 | Sales Q/Q | 21.39% | SMA20 | -3.06% ($21.01) | Beta | 0.8 | Target Price | $31.67 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/8/6 | SMA50 | -13.76% ($23.62) | Rel Volume | 1.04 | Prev Close | $20.42 |
| Employees | 1226 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 3.86% 5.91% | SMA200 | -12.23% ($23.21) | Avg Volume(3M) | 1.22M | Price | $20.37 |
| IPO | 2021/4/29 | Option/Short | Yes/Yes | Trades | 13119 | Volume | 1,263,426 | Change | -0.24% |
Company
PRVA is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A U.S. healthcare services company that provides a physician practice support platform. It offers physicians and medical groups a platform that supports clinical operations and value-based care, with exposure to expanding medical networks and the shift toward value-based care. The company operates in the physician practice support platform space.
Over the past 1 year, on the lower side
29% below its 1-year high.
PRVA makes money exceptionally well
1.9% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +43.1% this year.
Tap to view numbers
But it is not cheap
Trading at 94.5 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -19.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 93.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HEAL 0.02%
XHS 0.02%
LGHT 0.02%
FMED 0.01%
BREW 0.01%It ranks #4 in the industry
Based on market cap of $3B.
PRVA $3B PER 94.5
VEEV $42B PER 42.9
BTSG $11B PER 43.2
TEM $11B PER -
FAQ
What kind of company is PRVA?
PRVA belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of PRVA?
The market cap of PRVA is approximately $2.6B, ranking 1,897 within its sector.
What is the P/E ratio of PRVA?
PRVA has a P/E ratio of approximately 94.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PRVA?
PRVA has recorded a 52-week high of $28.82 and a low of $19.53.
